Current status of treatment and disease burden of a cohort of hemophilia B in China
ObjectiveHemophilia B is a rare X-chromosome linked hereditary bleeding disorder. Patients require lifelong treatment and it is costly, but there is a lack of research in China on the treatment and burden for this group. Our aim was to review the actual treatment pattern of hemophilia B patients in...
Saved in:
Main Authors: | Yiwen Huang (Author), Chuchuan Wan (Author), Tao Guan (Author), Xiaoyu Xi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The influence of non-clinical pharmacists' understanding of and attitudes towards pharmaceutical care on their willingness to serve as clinical pharmacists in China
by: Chuchuan Wan, et al.
Published: (2022) -
Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM)
by: Meryl Brod, et al.
Published: (2023) -
Mapping health assessment questionnaire disability index onto EQ-5D-5L in China
by: Chuchuan Wan, et al.
Published: (2023) -
Mapping the Peds QLTM 4.0 onto CHU-9D: a cross-sectional study in functional dyspepsia population from China
by: Qiqi Wang, et al.
Published: (2023) -
Sports and Children with Hemophilia: Current Trends
by: Lorenzo Moretti, et al.
Published: (2021)